Labour & Employment

EU Mental Health Disability Benefits — Social Protection Expenditure (2012–2023)

Annual social protection expenditure on mental health-related disability benefits across the EU-27, sourced from Eurostat ESSPROS. Tracks the fiscal cost of workers exiting employment due to psychiatric disorders, depression, burnout, and anxiety — from €37.2 billion in 2012 to €65.5 billion in 2023.

Updated April 14, 2026 Annual Eurostat (European Commission) — ESSPROS

EU-27 Mental Health Disability Spend (2023)

€65.5bn

Mental health cash disability benefits

+76% since 2012

Share of Disability Benefits — Mental Health

~37%

OECD estimate across six EU countries

Was ~25% in mid-2000s

Work-Related Stress / Depression / Anxiety (EU, 2020)

1.9%

% of employed EU workers aged 15–64

Sweden alone: 8.6% of workers

Pandemic Surge (2019–2020)

+10.8%

Largest single-year rise in the series

€49.1bn → €54.4bn

Data

Year	EU-27 (€bn)	YoY Change	Belgium (€bn)	Germany (€bn)	France (€bn)
2023	65.5	+8.5%	2.73	24.2	13.2
2022	60.4	+5.5%	2.44	22.3	12.4
2021	57.3	+5.2%	2.04	21.4	11.6
2020	54.4	+10.8%	1.88	20.6	11.5
2019	49.1	+6.5%	1.81	18.2	10.7
2018	46.1	+4.8%	1.68	17.1	10.0
2017	44.0	+3.0%	1.49	16.4	9.7
2016	42.7	+4.1%	1.44	15.7	9.4
2015	41.0	+2.1%	1.38	14.9	9.1
2014	40.2	+3.9%	1.42	14.3	8.8
2013	38.7	+4.0%	1.39	13.4	8.5
2012	37.2	—	1.36	13.0	8.1

About this Dataset

The EU-27 spent €65.5 billion on mental health-related disability benefits in 2023 — 76% more than the €37.2 billion recorded in 2012. That trajectory, captured annually through Eurostat’s ESSPROS system, tells a story of structural deterioration in workforce mental health that pre-dates COVID-19 and has accelerated through it. The data tracks cash transfers — disability pensions, long-term sickness benefits, and early retirement payments — registered under psychiatric diagnostic codes in national social security systems. These are not self-reported surveys or modelled estimates; they are administrative fiscal flows representing the direct public cost of workers who have permanently or semi-permanently exited employment due to mental illness.

In Belgium alone, more than 526,000 people were receiving long-term disability benefits by end-2023, with psychiatric disorders accounting for 38% of all cases — and Belgium spent over €2 billion on mental health-related long-term sickness benefits in 2023, a 74% increase since 2018.

The pandemic year of 2020 produced the sharpest single-year increase in the series — a 10.8% jump from €49.1 billion to €54.4 billion — but the critical analytical point is that expenditure has not normalised in the years since. Germany’s mental health disability outlay rose from €13.0 billion in 2012 to €24.2 billion in 2023; France’s from €8.1 billion to €13.2 billion; Belgium’s doubled from €1.36 billion to €2.73 billion. These are not cyclical fluctuations. Across the OECD’s multi-country research, mental disorders now account for approximately 37% of all disability benefit expenditure — a share that has roughly doubled over the past two decades as musculoskeletal conditions, historically the dominant diagnostic category, have given way to psychiatric disorders, depression, and burnout as the primary drivers of permanent work incapacity inflows.

The Eurostat EU Labour Force Survey’s 2020 ad-hoc module adds a complementary workplace-level picture: 44.6% of the total employed EU population aged 15–64 reported facing risk factors for their mental well-being at work, with time pressure and work overload cited by nearly one in five workers. Some 1.9% of EU workers aged 15–64 reported a work-related health problem classified as stress, depression, or anxiety — a figure that reaches 8.6% in Sweden and 3.6% in Luxembourg. These prevalence rates feed the disability pipeline: approximately 16% of all work-related health problems in the EU are described as stress, depression, or anxiety, and mental health conditions characteristically lead to longer absence spells and lower return-to-work rates than physical injuries.

Dataset: Eurostat ESSPROS DSB_SPREX03 — social protection expenditure on disability, mental health (MT) category, cash benefits, million EUR
Methodology: ESSPROS harmonised administrative data from national social security authorities; mental health category isolates psychiatric diagnostic codes within disability benefit registers
Geographic scope: EU-27 aggregate plus Belgium, Germany, France country detail; 2012–2023 annual coverage
Supplementary sources: OECD Mental Health and Work series (2012–2015 country reports); Eurostat LFS 2020 ad-hoc module on work-related health problems; EU-OSHA ESENER surveys
Key caveat: ESSPROS captures public social protection expenditure only — employer-funded occupational health insurance and private sick pay schemes are excluded, meaning total societal cost is materially higher than the figures shown

For corporate strategy teams and PE/VC investors assessing European labour market risk, this dataset provides one of the few systematic, annually updated measures of mental health-driven workforce attrition at EU scale. The implied human capital loss — workers permanently exiting employment before retirement age due to psychiatric conditions — represents a structural headwind to productivity growth and a rising component of the EU’s social protection fiscal burden.

Frequently Asked Questions

The dataset tracks social protection expenditure specifically attributed to mental health-related disability benefits across the EU-27, sourced from Eurostat's European System of Integrated Social Protection Statistics (ESSPROS). ESSPROS is a harmonised framework that collects administrative data from national social security systems; the mental health (MT) category isolates cash transfers — disability pensions, sickness benefits, and early retirement payments — recorded under psychiatric diagnostic codes. Because it captures public expenditure rather than case counts, the series reflects both the volume of beneficiaries and the average benefit value, making it sensitive to both epidemiological trends and policy changes in replacement rates.

Mental health conditions have become the leading diagnostic category for long-term sick leave and disability benefit inflows across most EU member states — a structural shift that has occurred over the past two decades. OECD research estimates that mental disorders now account for approximately 37% of all disability benefit expenditure in the six EU countries studied (Austria, Belgium, Denmark, Netherlands, Sweden, United Kingdom), up from around 25% in the mid-2000s. In Belgium, by the end of 2023 more than 526,000 people were receiving long-term disability benefits, with psychiatric disorders responsible for nearly 38% of all cases — including 137,454 individuals diagnosed specifically with depression or burnout. Among workers under age 30, the Belgian INAMI data recorded a 21.6% jump in mental health-related disability cases in a single year.

The 10.8% year-on-year jump in EU-27 mental health disability expenditure in 2020 — from €49.1 billion to €54.4 billion — reflects two concurrent forces: a genuine acceleration in mental health deterioration during the pandemic (isolation, job insecurity, remote-work stress), and temporary policy expansions in several member states that eased access to sickness and disability benefits. Critically, expenditure has not retreated after the pandemic; the series has continued rising each year, reaching €65.5 billion in 2023. This persistence distinguishes the COVID episode from a temporary shock and indicates structural demand growth. Germany's mental health disability expenditure alone rose from €20.6 billion in 2020 to €24.2 billion in 2023, a 17.5% increase in three post-pandemic years.

Within the EU, Belgium and the Nordic countries — particularly Denmark and Sweden — carry the highest mental health disability expenditure as a share of GDP, a pattern that reflects both generous benefit generosity and relatively high rates of diagnosis and reporting. Denmark's mental health disability cash spend represented 2.82% of GDP in 2023, compared with an EU-27 weighted average of 0.38%. Germany dominates in absolute terms given its population size, but Belgium is notable for the pace of growth: its mental health disability outlay rose from €1.36 billion in 2012 to €2.73 billion in 2023, a 101% nominal increase. Southern and Eastern European countries (Bulgaria, Romania, Hungary, Baltic states) report near-zero mental health-specific disability expenditure — reflecting differences in diagnostic practice, benefit architecture, and stigma around psychiatric diagnoses rather than lower underlying prevalence.

For financial sponsors and credit investors evaluating European mid-market businesses, rising mental health disability expenditure signals multiple intersecting risks. In human-capital-intensive sectors — technology, professional services, healthcare, education — elevated mental health absenteeism directly compresses EBITDA through replacement costs, productivity losses, and rising employer insurance premiums. In labour-scarce markets such as Germany and the Netherlands, long-term mental health exits reduce the pool of skilled workers, supporting wage inflation and undermining operating leverage assumptions in investment models. On the credit side, leveraged issuers with workforce exposure in Belgium and the Nordic countries face a structurally rising labour cost base as mental health-related sick pay obligations expand. ESG-oriented LPs are increasingly requesting portfolio companies to disclose mental health absenteeism rates as part of social KPI reporting, making this data relevant to exit valuation multiples in health-conscious acquirer pools.

Three factors limit direct cross-country comparison. First, classification practice varies: in several Eastern European countries, long-term sick workers are recorded under musculoskeletal or general disability categories rather than psychiatric codes, artificially deflating the mental health share of reported expenditure. Second, benefit generosity differs substantially — Denmark's high per-capita expenditure partly reflects a generous replacement rate structure rather than a proportionally higher caseload. Third, the ESSPROS mental health category (MT) captures only public social protection expenditure and excludes employer-funded occupational health insurance, private sickness funds, and occupational pension schemes, which are material in the Netherlands and Germany and represent significant additional economic cost. Analysts should treat the ESSPROS series as a lower bound on total societal cost and use it primarily as a directional trend indicator rather than an absolute measure of mental health burden.

Data

About this Dataset

Frequently Asked Questions

Related Datasets